Observational Study of the Quality of Life for the Chronic Pain Patients Included in a Therapeutic Education Program Focused on Relaxation Techniques (QOLPain)

June 14, 2022 updated by: Centre Hospitalier Metropole Savoie

The benefit of learning psychocorporal techniques in Therapeutic Education on the quality of life of patients with chronic pain will be studied.

The purpose of this nursing research protocol is to highlight the improvement of the quality of life of chronic pain patients through psycho-physical techniques performed during group therapeutic education workshops.

Study Overview

Detailed Description

The study will be performed at Centre for the Study and Treatment of Pain. The patients with chronic pain will participate to a group programm of therapeutic education.

The programm consists of 9 workshops about psycho-corporal techniques performed in group.

The patients will complete questionnaries before beginning the program, at the end of the programm, 6 months after the end of the program, and 12 months after the end of program.

The questionnaries will be SF36, HADS, CPAQ, and digital pain scale.

Study Type

Observational

Enrollment (Anticipated)

72

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Chambéry, France, 73011
        • Recruiting
        • CH Métropole Savoie
        • Principal Investigator:
          • Valérie Roullot-Pradel
        • Contact:
          • Patricia Triolo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patient with chronic pain for whom a group "relaxation techniques" programm is planned and accepted by the patient.

Description

Inclusion Criteria:

  • chronic pain since more the 3months
  • Patients for whom a group "relaxation techniques" program is planned and accepted by the patient

Exclusion Criteria:

  • Patient with progressive cancer pain
  • severe psychiatric pathology (example: psychosis, deep melancholy)
  • Patient not compliant or refusing to participate in research
  • Person who does not understand French, or illiterate
  • Person physically unable to complete questionnaires (visually impaired or blind)
  • Person protected by sections L1121-5 to L1121-8.1 of the French Public Health Code

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patient with chronic pain

This is a validate questionnary:

Ware et al,1992, McHorney et al, 1993, McHorney et al, 1994 French version : Author : Alain Leplège; et coll. En 2001

Other Names:
  • 36 items Medical Outcome Study Short Form health survey
this is a validate scale: author: Zigmond A.S., Snaith R.P. in 1983
Other Names:
  • HADS

This is a validate questionnaire:

Fish, R., McGuire, B.E., Hogan, M., Stewart, I. & Morrison, T. (2010).

Other Names:
  • CPAQ
this is a validate scale A.N.A.E.S. February 1999

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of quality of life during the program
Time Frame: score at the end of the workshop compared to the score at the beginning
SF36 score
score at the end of the workshop compared to the score at the beginning

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in quality of life
Time Frame: Comparison between the beginning of the program and twelve months after the end of the program.
assessed by sf36 score
Comparison between the beginning of the program and twelve months after the end of the program.
Change in anxiety and depression
Time Frame: Comparison at different moments in time - beginning, end, 6 months after, 12 months after
assessed by HADS
Comparison at different moments in time - beginning, end, 6 months after, 12 months after
Change in perceived pain
Time Frame: Assessment at the beginning of the program and 12 months after the end using a numerical pain scale
assessed by numeric pain scale
Assessment at the beginning of the program and 12 months after the end using a numerical pain scale
Evolution in patient's acceptance of chronic pain:after the end
Time Frame: Comparison at different moments in time - beginning, end, 6 months after, 12 months after
assessed by Chronic Pain Acceptance Questionnaire
Comparison at different moments in time - beginning, end, 6 months after, 12 months after
Change in physical activity
Time Frame: Change in physical activity between the beginning of the program and 12 months after the end
assessed by SF36 Physical Activity Sub-Scale
Change in physical activity between the beginning of the program and 12 months after the end

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Valérie Roullot-Pradel, CH Métropole Savoie

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2020

Primary Completion (Anticipated)

October 2, 2022

Study Completion (Anticipated)

October 2, 2023

Study Registration Dates

First Submitted

January 7, 2020

First Submitted That Met QC Criteria

August 28, 2020

First Posted (Actual)

September 2, 2020

Study Record Updates

Last Update Posted (Actual)

June 15, 2022

Last Update Submitted That Met QC Criteria

June 14, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on questionnary SF36

Subscribe